期刊文献+

异种肝细胞移植对大鼠药物性肝衰存活率和肝功能的影响 被引量:2

Survival rate and hepatic function of xenogenic hepatocyte transplantation in the treatment of rat toxic hepatic failure
下载PDF
导出
摘要 目的 观察异种肝细胞移植对大鼠药物性肝衰的存活率和肝功能的影响。方法 豚鼠为供体 ,海藻酸钠 氯化钡法微囊化。SD大鼠为受体 ,氨基半乳糖腹腔内一次性注射制作肝衰模型。 4 8h后将微囊化豚鼠肝细胞 (1 5× 10 7个 )移植于大鼠脾脏内。豚鼠裸肝细胞 (1 5× 10 7个 )移植及生理盐水 1 2ml脾脏注射为对照。移植后观察受体大鼠 14d存活率和肝功能的改变。结果 微囊化肝细胞移植组存活率 80 % ,明显高于生理盐水组 (2 5 % )和裸肝细胞移植组 (70 % ) (P <0 0 1与P <0 0 5 )。微囊化肝细胞移植组 14d总胆红素 (0 6 8± 0 0 5 μmol/L)和ALT(5 5± 6 7U/L) ,明显低于生理盐水组 (0 82± 0 0 7μmol/L和 91 0± 8 0U/L)和裸肝细胞组 (0 76± 0 0 6 μmol/L和 74 0±7 1U/L) (P <0 0 5和P <0 0 1)。总蛋白 (117 0± 8 4 g/L)和球蛋白 (6 6 0± 5 6 g/L) ,明显高于对照组 (78 0± 6 9g/L和 4 3 0± 6 2 g/L)、(96 0± 7 4 g/L和 5 2 0± 6 9g/L) (P <0 0 5与P <0 0 1)。结论 药物性肝衰大鼠脾内移植微囊化异种肝细胞有显著逆转肝功能和提高生存率的作用。 Objective To observe the survival rate and hepatic function of xenogenic encapsulated hepatocytes transplantation(XHT) in the treatment of toxic hepatic failure(THF) in SD rats.Methods Twenty SD rats received intraspleen graft of 1 5×10 7 guinea pig encapsulation hepatocytes by alginate barium at 48h after D galactosamine intraperitoneal injection(19 5mg·kg) Other two groups were guinea pig free hepatocytes transplantation(1 5×10 7)(FHT group, n= 20)and 1 2ml of normal saline injection(NS group, n= 20)serving as control.The survival rate and hepatic function were recorded at 14 days after transplatation.Results The survival rate of XHT group was as high as 80%,obviously higher than that of THF group(70%)and NS group(25%)( P< 0 01 vs P< 0 05).Total bilirubin(0 68±0 05μmol/L)and ALT(55±6 7U/L)of the XHT group were lower than those of NS group(0 82±0 07μmol/L vs 91±8 0U/L) and FHT group(0 76±0 06μmol/L vs 74 0±7 1U/L)( P< 0 05 vs P< 0 01).Total albumin(117 0±8 4g/L and globulin(66 0±5 6g/L)were higher than that of control group(78±6 9g/L vs 43±6 2g/L;96±7 4g/L vs 52±6 9g/L)( P< 0 05 vs P< 0 01).Conclusion Hepatic function and survival rate of the hepatic failure rats induced by D galactosamine were improved obviously after transplanting encapsulated xenogeneic hepatocytes.
出处 《江苏医药》 CAS CSCD 北大核心 2002年第9期671-673,共3页 Jiangsu Medical Journal
关键词 异种移植 肝细胞移植 海藻酸钠 豚鼠 SD大鼠 Heterologus Hepatocyte transplantation Alginate barium Guinea pig SD rat
  • 相关文献

参考文献3

二级参考文献4

  • 1Gomez N,Balladur P,Calmus Y,et al.Evidence for survival and metabolic activity of encapsulated xenogeneic hapatocytes transplanted without immunosuppression in gunn rats[].Transplantation.1997
  • 2Cappai A,Petruzzo P,Ruiu G,et al.Evaluation of new small barium alginate microcapsules[].International Journal of Artificial Organs.1995
  • 3Soon-Shiong P,Feldman E,Nelson R,et al.Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets[].Transplantation.1992
  • 4Demma J,Honssin D,Capron M,et al.Therapeutic efficacy of transplantation of isolated hepatocytes in rats with surgically induced acute hepatic failure: a study of the mechanism[].European Surgical Research.1986

共引文献19

同被引文献35

  • 1Lim F,Sun AM.Microencapsulated islets as bioartificial endocrine pancreas.Science,1980,210:908-912.
  • 2Sarkis R.Transplanted cryopreserved encapsulated porcine hepatocytes are as effective as fresh hepatocytes in preventing death from acute liver failure in rats.Transplantation,2000,70:58-64.
  • 3Bruni S,Chang TM.Kinetic analysis of UDP-glucuronosyltransferase in bilirubin conjugation by encapsulated hepatocytes for transplantation into gunn rats.Artif Organs,1995,19:449.
  • 4Dixit V,Arthur M.Repeated transplantation of microencapsulated hepatocytes for sustained correction of hyperbilirubinemia in Gunn rats.Cell Transplant,1992,1:275-280.
  • 5Mai G,Huy NT,Morel P,et al.Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.Transplant Proc,2005,37:527-529.
  • 6Allen KJ, Soriano HE. Liver cell transplantation: the road to clinical application. J Lab Clin Med, 2001,138:298-312.
  • 7Nagata H, Ito M, Cai J, et al. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology, 2003, 124: 422-431.
  • 8Ramirez P, Chavez R, Majado M, et al. Life-supporting human complement regulatory decay accelerating factor transgenic pic liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation, 2000,70:989-998.
  • 9Cascio SM. Novel strategies for immortalization of human hepatocytes. Artificial Organs, 2001, 25:529-538.
  • 10Kobayashi N, Fujiwara T, Westerman KA, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science, 2000, 287: 1258-1262.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部